No abstract
Heart. 2026 Sep 15:heartjnl-2026-328899. doi: 10.1136/heartjnl-2026-328899. Online ahead of print.
NO ABSTRACT
PMID:42744604 | DOI:10.1136/heartjnl-2026-328899
Elusive benefit of mineralocorticoid receptor antagonists in transthyretin cardiac amyloidosis: where do we stand?
Scritto il 15/09/2026
da Matteo Serenelli